Cleared Traditional

BARD COLLAMEND IMPLANT, MODELS 1175102, 1175103, 1175104, 1175105, 1175106 (K063178) - FDA 510(k) Clearance

Class II General & Plastic Surgery device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K063178 · C.R. Bard, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2006
Decision
33d
Days
Class 2
Risk

K063178 is an FDA 510(k) clearance for the BARD COLLAMEND IMPLANT, MODELS 1175102, 1175103, 1175104, 1175105, 1175106. Classified as Mesh, Surgical (product code FTM), Class II - Special Controls.

Submitted by C.R. Bard, Inc. (Canston, US). The FDA issued a Cleared decision on November 21, 2006 after a review of 33 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.3300 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all C.R. Bard, Inc. devices

Submission Details

510(k) Number K063178 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 19, 2006
Decision Date November 21, 2006
Days to Decision 33 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
82d faster than avg
Panel avg: 115d · This submission: 33d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FTM Mesh, Surgical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.3300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - FTM Mesh, Surgical

All 162
Devices cleared under the same product code (FTM) and FDA review panel - the closest regulatory comparables to K063178.
Endoform Reconstructive Template - PLGA
K250598 · Aroa Biosurgery , Ltd. · Jun 2025
OviTex PRS (Long-Term Resorbable)
K243595 · TELA Bio, Inc. · Dec 2024
CanGaroo RM Antibacterial Envelope
K233991 · Elutia, Inc. · Jun 2024
OviTex PRS
K241126 · TELA Bio, Inc. · May 2024
Peri-Guard and Supple Peri-Guard
K223052 · Synovis Life Technologies, Inc. · Apr 2023
OviTex PRS (Long Term Resorbable)
K214070 · Tela Bio · Mar 2023